; (ii) as applicable, information collected from drug manufacturers by such plan on the total amount of copayment assistance dollars paid, or copayment cards applied, that were funded by applicable drug manufacturers with respect to the participants and beneficiaries in such plan, except that such information shall not identify any drug manufacturer